Instant NanoBiosensors
Taipei, Taiwan· Est.
A Taiwan startup delivering rapid, fiber‑optic biosensing and automated NGS workflows for precision diagnostics.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
A Taiwan startup delivering rapid, fiber‑optic biosensing and automated NGS workflows for precision diagnostics.
NeurologyOncologyInfectious DiseaseGenomics
Technology Platform
FOPPR™ (Fiber‑Optic Particle Plasmon Resonance) provides label‑free, real‑time optical detection of biomarkers, while the iNA™ suite automates nucleic‑acid extraction and NGS library preparation for high‑throughput precision diagnostics.
Opportunities
Rapid, multiplexed biomarker testing for early disease detection and the growing demand for automated NGS workflows in hospitals present significant upside.
Risk Factors
Regulatory hurdles for in‑vitro diagnostics, competition from established assay vendors, and the need for sustained capital to scale manufacturing could impede growth.
Competitive Landscape
INB differentiates itself by combining label‑free optical sensing with end‑to‑end NGS automation, a niche not fully addressed by pure sequencing or immunoassay companies.